Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis.

Hoffmann-Vold AM, Weigt SS, Palchevskiy V, Volkmann E, Saggar R, Li N, Midtvedt Ø, Lund MB, Garen T, Fishbein MC, Ardehali A, Ross DJ, Ueland T, Aukrust P, Lynch JP 3rd, Elashoff RM, Molberg Ø, Belperio JA.

PLoS One. 2018 Nov 20;13(11):e0206545. doi: 10.1371/journal.pone.0206545. eCollection 2018.

2.

Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts.

Volkmann ER, Tashkin DP, Sim M, Li N, Goldmuntz E, Keyes-Elstein L, Pinckney A, Furst DE, Clements PJ, Khanna D, Steen V, Schraufnagel DE, Arami S, Hsu V, Roth MD, Elashoff RM, Sullivan KM; SLS I and SLS II study groups.

Ann Rheum Dis. 2018 Nov 8. pii: annrheumdis-2018-213708. doi: 10.1136/annrheumdis-2018-213708. [Epub ahead of print]

PMID:
30409830
3.

Randomized phase II study of fulvestrant and erlotinib compared with erlotinib alone in patients with advanced or metastatic non-small cell lung cancer.

Garon EB, Siegfried JM, Stabile LP, Young PA, Marquez-Garban DC, Park DJ, Patel R, Hu EH, Sadeghi S, Parikh RJ, Reckamp KL, Adams B, Elashoff RM, Elashoff D, Grogan T, Wang HJ, Dacic S, Brennan M, Valdes Y, Davenport S, Dubinett SM, Press MF, Slamon DJ, Pietras RJ.

Lung Cancer. 2018 Sep;123:91-98. doi: 10.1016/j.lungcan.2018.06.013. Epub 2018 Jun 22.

PMID:
30089602
4.

Acute Effect of Hookah Smoking on Arterial Stiffness and Wave Reflections in Adults Aged 18 to 34 Years of Age.

Rezk-Hanna M, Doering L, Robbins W, Sarna L, Elashoff RM, Victor RG.

Am J Cardiol. 2018 Sep 1;122(5):905-909. doi: 10.1016/j.amjcard.2018.05.033. Epub 2018 Jun 5.

PMID:
30057235
5.

A Trial of Blood-Pressure Reduction in Black Barbershops.

Victor RG, Blyler C, Elashoff RM.

N Engl J Med. 2018 Jul 12;379(2):200-201. doi: 10.1056/NEJMc1806026. No abstract available.

PMID:
29996084
6.

A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops.

Victor RG, Lynch K, Li N, Blyler C, Muhammad E, Handler J, Brettler J, Rashid M, Hsu B, Foxx-Drew D, Moy N, Reid AE, Elashoff RM.

N Engl J Med. 2018 Apr 5;378(14):1291-1301. doi: 10.1056/NEJMoa1717250. Epub 2018 Mar 12.

7.

The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation.

Shino MY, Weigt SS, Li N, Palchevskiy V, Derhovanessian A, Saggar R, Sayah DM, Huynh RH, Gregson AL, Fishbein MC, Ardehali A, Ross DJ, Lynch JP 3rd, Elashoff RM, Belperio JA.

PLoS One. 2017 Jul 7;12(7):e0180281. doi: 10.1371/journal.pone.0180281. eCollection 2017.

8.

The Prognostic Importance of Bronchoalveolar Lavage Fluid CXCL9 During Minimal Acute Rejection on the Risk of Chronic Lung Allograft Dysfunction.

Shino MY, Weigt SS, Li N, Derhovanessian A, Sayah DM, Saggar R, Huynh RH, Gregson AL, Ardehali A, Ross DJ, Lynch JP Rd, Elashoff RM, Belperio JA.

Am J Transplant. 2018 Jan;18(1):136-144. doi: 10.1111/ajt.14397. Epub 2017 Aug 2.

PMID:
28637080
9.

Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma.

Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters MWJM, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DSB, Wang HJ, Elashoff DA, Elashoff RM.

N Engl J Med. 2017 Jun 8;376(23):2211-2222. doi: 10.1056/NEJMoa1613210.

10.

Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease: An Analysis of Scleroderma Lung Studies I and II.

Volkmann ER, Tashkin DP, Li N, Roth MD, Khanna D, Hoffmann-Vold AM, Kim G, Goldin J, Clements PJ, Furst DE, Elashoff RM.

Arthritis Rheumatol. 2017 Jul;69(7):1451-1460. doi: 10.1002/art.40114. Epub 2017 May 23.

11.

Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease.

Volkmann ER, Tashkin DP, Roth MD, Clements PJ, Khanna D, Furst DE, Mayes M, Charles J, Tseng CH, Elashoff RM, Assassi S.

Arthritis Res Ther. 2016 Dec 30;18(1):305. doi: 10.1186/s13075-016-1203-y.

12.

Improved Cough and Cough-Specific Quality of Life in Patients Treated for Scleroderma-Related Interstitial Lung Disease: Results of Scleroderma Lung Study II.

Tashkin DP, Volkmann ER, Tseng CH, Roth MD, Khanna D, Furst DE, Clements PJ, Theodore A, Kafaja S, Kim GH, Goldin J, Ariolla E, Elashoff RM.

Chest. 2017 Apr;151(4):813-820. doi: 10.1016/j.chest.2016.11.052. Epub 2016 Dec 22.

13.

Impact of Allograft Injury Time of Onset on the Development of Chronic Lung Allograft Dysfunction After Lung Transplantation.

Shino MY, Weigt SS, Li N, Derhovanessian A, Sayah DM, Huynh RH, Saggar R, Gregson AL, Ardehali A, Ross DJ, Lynch JP 3rd, Elashoff RM, Belperio JA.

Am J Transplant. 2017 May;17(5):1294-1303. doi: 10.1111/ajt.14066. Epub 2016 Oct 31.

14.

Systolic Blood Pressure as a Novel Determinant of Nocturia in Non-Hispanic Black Men.

Mason OR, Lynch K, Rashid M, Reid A, Elashoff RM, Victor RG.

J Am Soc Hypertens. 2016 Jul;10 Suppl 1:e6. doi: 10.1016/j.jash.2016.06.019. No abstract available.

PMID:
27677142
15.

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.

Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM; Sclerodema Lung Study II Investigators.

Lancet Respir Med. 2016 Sep;4(9):708-719. doi: 10.1016/S2213-2600(16)30152-7. Epub 2016 Jul 25.

16.

Why use sex hormones in relapsing-remitting multiple sclerosis? - Authors' reply.

Voskuhl R, Wang H, Elashoff RM.

Lancet Neurol. 2016 Jul;15(8):790-791. doi: 10.1016/S1474-4422(16)00129-0. No abstract available.

PMID:
27302354
17.

Acute Effect of Hookah Smoking on the Human Coronary Microcirculation.

Nelson MD, Rezk-Hanna M, Rader F, Mason OR, Tang X, Shidban S, Rosenberry R, Benowitz NL, Tashkin DP, Elashoff RM, Lindner JR, Victor RG.

Am J Cardiol. 2016 Jun 1;117(11):1747-54. doi: 10.1016/j.amjcard.2016.03.007. Epub 2016 Mar 18.

18.

Inverse association between altitude and obesity: A prevalence study among andean and low-altitude adult individuals of Peru.

Woolcott OO, Gutierrez C, Castillo OA, Elashoff RM, Stefanovski D, Bergman RN.

Obesity (Silver Spring). 2016 Apr;24(4):929-37. doi: 10.1002/oby.21401. Epub 2016 Mar 3.

19.

The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.

DerHovanessian A, Weigt SS, Palchevskiy V, Shino MY, Sayah DM, Gregson AL, Noble PW, Palmer SM, Fishbein MC, Kubak BM, Ardehali A, Ross DJ, Saggar R, Lynch JP 3rd, Elashoff RM, Belperio JA.

Am J Transplant. 2016 Feb;16(2):640-9. doi: 10.1111/ajt.13475. Epub 2015 Oct 13.

20.

Randomized phase 2 trial of erlotinib in combination with high-dose celecoxib or placebo in patients with advanced non-small cell lung cancer.

Reckamp KL, Koczywas M, Cristea MC, Dowell JE, Wang HJ, Gardner BK, Milne GL, Figlin RA, Fishbein MC, Elashoff RM, Dubinett SM.

Cancer. 2015 Sep 15;121(18):3298-306. doi: 10.1002/cncr.29480. Epub 2015 May 29.

21.

Development of a Composite Outcome Measure for Systemic Sclerosis Related Interstitial Lung Disease.

Volkmann ER, Tashkin DP, Li N, Furst DE, Clements PJ, Elashoff RM.

Rheumatology (Sunnyvale). 2015 Jun;5(2). pii: 154. doi: 10.4172/2161-1149.1000154. Epub 2015 Jun 30.

23.

Clinical Trials in Non-Small Cell Lung Cancer with Biomarker-Driven Treatment Allocation: Ready or Not, Here We Come.

Garon EB, Abarca PA, Strunck JL, Nameth D, Neumann C, Wolf B, Kim KY, Marx C, Elashoff RM.

Crit Rev Oncog. 2015;20(5-6):339-47. doi: 10.1615/CritRevOncog.v20.i5-6.70. Review.

24.

Inverse association between diabetes and altitude: a cross-sectional study in the adult population of the United States.

Woolcott OO, Castillo OA, Gutierrez C, Elashoff RM, Stefanovski D, Bergman RN.

Obesity (Silver Spring). 2014 Sep;22(9):2080-90. doi: 10.1002/oby.20800. Epub 2014 May 28.

25.

PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy.

Nelson MD, Rader F, Tang X, Tavyev J, Nelson SF, Miceli MC, Elashoff RM, Sweeney HL, Victor RG.

Neurology. 2014 Jun 10;82(23):2085-91. doi: 10.1212/WNL.0000000000000498. Epub 2014 May 7.

26.

Improved transplant-free survival in patients with systemic sclerosis-associated pulmonary hypertension and interstitial lung disease.

Volkmann ER, Saggar R, Khanna D, Torres B, Flora A, Yoder L, Clements PJ, Elashoff RM, Ross DJ, Agrawal H, Borazan N, Furst DE, Saggar R.

Arthritis Rheumatol. 2014 Jul;66(7):1900-8. doi: 10.1002/art.38623.

27.

CXCR3 ligands are associated with the continuum of diffuse alveolar damage to chronic lung allograft dysfunction.

Shino MY, Weigt SS, Li N, Palchevskiy V, Derhovanessian A, Saggar R, Sayah DM, Gregson AL, Fishbein MC, Ardehali A, Ross DJ, Lynch JP 3rd, Elashoff RM, Belperio JA.

Am J Respir Crit Care Med. 2013 Nov 1;188(9):1117-25. doi: 10.1164/rccm.201305-0861OC.

28.

Differential treatment of hypertension by primary care providers and hypertension specialists in a barber-based intervention trial to control hypertension in Black men.

Rader F, Elashoff RM, Niknezhad S, Victor RG.

Am J Cardiol. 2013 Nov 1;112(9):1421-6. doi: 10.1016/j.amjcard.2013.07.004. Epub 2013 Aug 23.

29.
30.

Cocaine-induced vasoconstriction in the human coronary microcirculation: new evidence from myocardial contrast echocardiography.

Gurudevan SV, Nelson MD, Rader F, Tang X, Lewis J, Johannes J, Belcik JT, Elashoff RM, Lindner JR, Victor RG.

Circulation. 2013 Aug 6;128(6):598-604. doi: 10.1161/CIRCULATIONAHA.113.002937. Epub 2013 Jun 28.

31.

Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study.

Weigt SS, Copeland CAF, Derhovanessian A, Shino MY, Davis WA, Snyder LD, Gregson AL, Saggar R, Lynch JP 3rd, Ross DJ, Ardehali A, Elashoff RM, Palmer SM, Belperio JA.

Am J Transplant. 2013 Apr;13(4):919-927. doi: 10.1111/ajt.12131. Epub 2013 Feb 7.

32.

Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome.

Lalezari S, Chou AP, Tran A, Solis OE, Khanlou N, Chen W, Li S, Carrillo JA, Chowdhury R, Selfridge J, Sanchez DE, Wilson RW, Zurayk M, Lalezari J, Lou JJ, Ormiston L, Ancheta K, Hanna R, Miller P, Piccioni D, Ellingson BM, Buchanan C, Mischel PS, Nghiemphu PL, Green R, Wang HJ, Pope WB, Liau LM, Elashoff RM, Cloughesy TF, Yong WH, Lai A.

Neuro Oncol. 2013 Mar;15(3):370-81. doi: 10.1093/neuonc/nos308. Epub 2013 Jan 17.

33.

Tadalafil alleviates muscle ischemia in patients with Becker muscular dystrophy.

Martin EA, Barresi R, Byrne BJ, Tsimerinov EI, Scott BL, Walker AE, Gurudevan SV, Anene F, Elashoff RM, Thomas GD, Victor RG.

Sci Transl Med. 2012 Nov 28;4(162):162ra155. doi: 10.1126/scitranslmed.3004327.

34.

An exploration of fixed and random effects selection for longitudinal binary outcomes in the presence of nonignorable dropout.

Li N, Daniels MJ, Li G, Elashoff RM.

Biom J. 2013 Jan;55(1):17-37. doi: 10.1002/bimj.201100107. Epub 2012 Nov 2.

35.

Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial.

Hoshimoto S, Shingai T, Morton DL, Kuo C, Faries MB, Chong K, Elashoff D, Wang HJ, Elashoff RM, Hoon DS.

J Clin Oncol. 2012 Nov 1;30(31):3819-26. doi: 10.1200/JCO.2011.40.0887. Epub 2012 Sep 24.

36.

Joint analysis of bivariate longitudinal ordinal outcomes and competing risks survival times with nonparametric distributions for random effects.

Li N, Elashoff RM, Li G, Tseng CH.

Stat Med. 2012 Jul 20;31(16):1707-21. doi: 10.1002/sim.4507. Epub 2012 Feb 17.

PMID:
22344869
37.
38.

CXCR3 chemokine ligands during respiratory viral infections predict lung allograft dysfunction.

Weigt SS, Derhovanessian A, Liao E, Hu S, Gregson AL, Kubak BM, Saggar R, Saggar R, Plachevskiy V, Fishbein MC, Lynch JP 3rd, Ardehali A, Ross DJ, Wang HJ, Elashoff RM, Belperio JA.

Am J Transplant. 2012 Feb;12(2):477-84. doi: 10.1111/j.1600-6143.2011.03859.x. Epub 2011 Dec 7.

39.

Patient education integrated with acupuncture for relief of cancer-related fatigue randomized controlled feasibility study.

Johnston MF, Hays RD, Subramanian SK, Elashoff RM, Axe EK, Li JJ, Kim I, Vargas RB, Lee J, Yang L, Hui KK.

BMC Complement Altern Med. 2011 Jun 25;11:49. doi: 10.1186/1472-6882-11-49.

40.

Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease.

Roth MD, Tseng CH, Clements PJ, Furst DE, Tashkin DP, Goldin JG, Khanna D, Kleerup EC, Li N, Elashoff D, Elashoff RM; Scleroderma Lung Study Research Group.

Arthritis Rheum. 2011 Sep;63(9):2797-808. doi: 10.1002/art.30438.

41.

A method to estimate treatment efficacy among latent subgroups of a randomized clinical trial.

Altstein LL, Li G, Elashoff RM.

Stat Med. 2011 Mar 30;30(7):709-17. doi: 10.1002/sim.4131. Epub 2010 Nov 30.

42.

Value of the new bone classification system in pediatric renal osteodystrophy.

Bakkaloglu SA, Wesseling-Perry K, Pereira RC, Gales B, Wang HJ, Elashoff RM, Salusky IB.

Clin J Am Soc Nephrol. 2010 Oct;5(10):1860-6. doi: 10.2215/CJN.01330210. Epub 2010 Jul 15.

44.

A general joint model for longitudinal measurements and competing risks survival data with heterogeneous random effects.

Huang X, Li G, Elashoff RM, Pan J.

Lifetime Data Anal. 2011 Jan;17(1):80-100. doi: 10.1007/s10985-010-9169-6. Epub 2010 Jun 12.

45.

Joint modeling of longitudinal ordinal data and competing risks survival times and analysis of the NINDS rt-PA stroke trial.

Li N, Elashoff RM, Li G, Saver J.

Stat Med. 2010 Feb 28;29(5):546-57. doi: 10.1002/sim.3798.

46.

CXCR4 expression on circulating pan-cytokeratin positive cells is associated with survival in patients with advanced non-small cell lung cancer.

Reckamp KL, Figlin RA, Burdick MD, Dubinett SM, Elashoff RM, Strieter RM.

BMC Cancer. 2009 Jun 29;9:213. doi: 10.1186/1471-2407-9-213.

47.

Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome.

Weigt SS, Elashoff RM, Huang C, Ardehali A, Gregson AL, Kubak B, Fishbein MC, Saggar R, Keane MP, Saggar R, Lynch JP 3rd, Zisman DA, Ross DJ, Belperio JA.

Am J Transplant. 2009 Aug;9(8):1903-11. doi: 10.1111/j.1600-6143.2009.02635.x. Epub 2009 May 13.

48.

CXCR3 ligands are augmented during the pathogenesis of pulmonary sarcoidosis.

Busuttil A, Weigt SS, Keane MP, Xue YY, Palchevskiy V, Burdick MD, Huang C, Zisman DA, Fishbein M, Lynch JP 3rd, Strieter RM, Elashoff RM, Belperio JA.

Eur Respir J. 2009 Sep;34(3):676-86. doi: 10.1183/09031936.00157508. Epub 2009 Apr 22.

49.

Response of different PTH assays to therapy with sevelamer or CaCO3 and active vitamin D sterols.

Wesseling-Perry K, Harkins GC, Wang HJ, Sahney S, Gales B, Elashoff RM, Jüppner H, Salusky IB.

Pediatr Nephrol. 2009 Jul;24(7):1355-61. doi: 10.1007/s00467-009-1143-8. Epub 2009 Mar 20.

50.

Robust joint modeling of longitudinal measurements and competing risks failure time data.

Li N, Elashoff RM, Li G.

Biom J. 2009 Feb;51(1):19-30. doi: 10.1002/bimj.200810491.

Supplemental Content

Loading ...
Support Center